^
    Back
    Association details:
    Biomarker:AJUBA overexpression
    Cancer:Cervical Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    New
    Source:
    Gene
    Title:

    AJUBA increases the cisplatin resistance through hippo pathway in cervical cancer

    Excerpt:
    ...AJUBA expression was significantly higher in the cervical cancer patients resistant to cisplatin treatment compared with cervical cancer patients sensitive to cisplatin treatment...overall survival time was significantly shorter in the cervical cancer patients with high AJUBA expression compare with those with low AJUBA expression...
    DOI:
    10.1016/j.gene.2017.11.017